Figure S2 from Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-grade Serous Tubo-ovarian Cancer

This is a Quantitative Study study.

Key Points

Molecular subtype distributions highlight significant differences between long-term and short-term survivors in ovarian cancer.
In the Charité cohort, distinct molecular subtypes were identified, showcasing survival variances that could guide treatment strategies.
The analysis involved comparing data from both the Charité cohort and the TCGA cohort, revealing crucial insights into cancer biology.
These findings emphasize the need for further research to uncover targeted therapies for advanced high-grade serous tubo-ovarian cancer.

Analysis compares molecular subtypes in long-term and short-term survivors of high-grade serous tubo-ovarian cancer, implicating survival outcomes.

Figure S2 displays the Proportions of Molecular subtypes of LTS and STS in the Charité cohort and n the TCGA cohort.

No takes yet. Share an insight, caveat, or question.

Marchenko et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share